Navigation Links
BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients
Date:3/24/2008

gap of less than or equal to 35 days.

Viral load reduction in chronic hepatitis B patients treated with BARACLUDE(R) (entecavir) in nucleoside-naive and lamivudine-refractory studies was also evaluated.

Data Results

Results from these studies prior to this year five analysis were previously announced on April 14, 2007.

Nucleoside-naive data

-- The incidence of BARACLUDE resistance in patients in

nucleoside-naive studies over time is low, with a cumulative

probability of genotypic BARACLUDE resistance of 1.2 percent

through five years.

-- No nucleoside-naive patient developed resistance (n=108) in year

five.

-- 93 percent of the nucleoside-naive patients taking BARACLUDE were

able to achieve and maintain an undetectable viral load

(HBV DNA <300 copies/mL) through year five (n=108).

Lamivudine-refractory data

-- The results in lamivudine-refractory patients in years one through

five were consistent with the finding that the pre-existence of

lamivudine-resistant substitutions resulted in an increase in the

emergence of BARACLUDE resistance, with a cumulative probability of

genotypic resistance of 51 percent through five years.

-- In year five, 43 percent of lamivudine-refractory patients had

virologic breakthrough with BARACLUDE resistance (n=33).

-- During this resistance monitoring program, 68 of the 187

lamivudine-refractory patients achieved undetectable viral load

(<300 copies/mL) and of these, one patient developed virologic

breakthrough due to BARACLUDE resistance.

Indication and Important Safety Information About BARACLUDE(R) (entecavir) 0.5 mg/1 mg Tablets

BARACLUDE(R) (entecavir) is a prescription medicine used for chronic infection with hepatitis B virus (HBV) in adults where the virus is multiplying and
'/>"/>

SOURCE Bristol-Myers Squibb
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Carpet One Floor & Home Continues Making Dramatic Strides in Funding Breast Cancer Research and Awareness
2. Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
3. New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ
4. Phase I and Phase I/II DCVax(R)-Brain Data Continues to Show Significantly Improved Survival Rates for Brain Cancer Patients
5. Bone Mineral Content Continues to Increase in Obese Adolescents During Weight Loss
6. Raven Announces Continued Enrollment of Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
7. The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement
8. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
9. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
10. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
11. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... , April 24, 2015   Vestagen Technical ... technology, VESTEX ® , has recently received two notable ... a global competition that recognizes innovations with potential to ... ceremony last night in New York City ... the Material Science "Protection & Safety" category. The awards ...
(Date:4/24/2015)... Apr. 24, 2015 Research and Markets ... the addition of the "Lab Accessories ... Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station) & End User (OEM/Biotechnology ... Forecast to 2020" report to their ... market is expected to reach $504.7 million ...
(Date:4/24/2015)... , April 24, 2015 Hi-Tech Pharmaceuticals ... was not the product of reliable scientific principles ... reliable basis for allegations of adulteration. The FDA ... a false premise, or misguided hope, that Methylphenylethylamine ... studies are contradicted by multiple other studies and ...
Breaking Medicine Technology:VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 2VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 3Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 3Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 2Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 3Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 4Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 5Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 6
... Kimberly-Clark Corporation (NYSE: KMB ) announced today ... business, which includes a number of innovative, minimally-invasive radio-frequency ... the exclusive distributor of Baylis Medical,s pain management products ... improves the competitive position of Kimberly-Clark Health Care in ...
... Oct. 5 US Oncology, Inc. ... (EHR) system, iKnowMed , at the American ... EHR Symposium: Harnessing the EHR: From Incentives to Sustainability ... iKnowMed(TM) addresses the unique needs of community-based medical oncologists. The ...
Cached Medicine Technology:Kimberly-Clark Acquires Baylis Medical Company's Pain Management Business 2Kimberly-Clark Acquires Baylis Medical Company's Pain Management Business 3US Oncology, Inc. to Exhibit iKnowMed(TM) at the 2009 ASCO EHR Symposium: Harnessing the EHR: From Incentives to Sustainability 2US Oncology, Inc. to Exhibit iKnowMed(TM) at the 2009 ASCO EHR Symposium: Harnessing the EHR: From Incentives to Sustainability 3
(Date:4/25/2015)... (PRWEB) April 25, 2015 For thirteen years, ... premier income protection education event in the nation! This year, ... The Plus Group, US to take DI Day on the ... George G. Davidson, CLU, ChFC, RHU, DIA, CLTC, Chief Executive ... DI Day reflects on the change by stating, "The first ...
(Date:4/24/2015)... York, NY (PRWEB) April 24, 2015 ... sober living residence in Westchester County. Just 35 miles ... help transition individuals back into everyday life while recovering ... Thursday, May 7, 2015, will allow therapists, doctors and ... areas and learn more about the opportunities offered by ...
(Date:4/24/2015)... 24, 2015 As the nation recognizes ... unique sacrifices of these young men and women, the ... Veterans and their Families” presents a special training session ... to gain a better understanding of the effect of ... For those – civilian and military – who provide ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Carvers' ... to have a successful biking day in Breck. ... just five minutes walking distance from Breckenridge, this ... well-versed in both Breckenridge bike rentals ( http://www.breckenridgeskishop.com/en/rent-equipment ... to offer extensive bike rentals in May 2015. ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Lipitor ... forward in the federal multidistrict litigation underway in ... to court documents, the parties involved in the ... 16th detailing, among other things, preparation for the ... counsel for both plaintiffs and defendants have conducted ...
Breaking Medicine News(10 mins):Health News:Secura Consultants Takes DI Day On The Road 2Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 2Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 3Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2Health News:Carvers Breckenridge Bike Rentals Offers Demo Mountain, Tandem, Bike Path Cruiser & JR. Bikes in May 2015 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3
... Corporation,(NYSE: SYK ) announced today a series of ... bench and position it for continued,success., Si Johnson, ... successful 29-year career with Stryker. It would be,impossible to ... Stryker over,these years, but what is very clear is ...
... HEPA filter lasting 6-9 months with continuous daily use ... including a UV lamp life that kills airborne bacteria ... in the United States made with absolutely no lead ... 24-hour programmable Paralda is the most powerful and energy ...
... advance screening and clinical research available nationwide, BETHESDA, ... Diabetes Day (Nov. 14) -- Diabetes in Children and ... Johnson. Diagnosed,with type 1 diabetes at age 19, she ... her disease are about 1 in 25., Due ...
... 10 MGT Capital Investments,Inc. (Amex: MGT ... Healthcare,Information Technology ("HCIT") sector, today reported financial results,for ... provided an update on,strategic milestones., Tim Paterson-Brown, ... of 2008 Medicsight continues to make progress towards ...
... Sponsored by Little Tikes, the Afternoon Raised Money and Awareness for ... ... 10 Hundreds of families,joined hosts Jenny McCarthy and Joely Fisher ... Social Club on,Sunday, November 9, 2008. Founded by Harvard graduates Michael ...
... Join the leading pharma executives redefining the ... challenges of driving,world class procurement, LONDON, ... times,pharmaceutical organisations are dramatically re-evaluating their business,models. ... is greater than,ever and board of directors ...
Cached Medicine News:Health News:Stryker Announces Organizational and Leadership Changes 2Health News:Stryker Announces Organizational and Leadership Changes 3Health News:Stryker Announces Organizational and Leadership Changes 4Health News:For the First Time this Winter Consumers Have an Electronic Green Solution that Eliminates 99.97 Percent of Indoor Air Pollution 2Health News:Former Miss America Nicole Johnson Takes Action for Type 1 Diabetes Research 2Health News:MGT Capital Investments Reports Third Quarter 2008 Financial Results and Provides Update on Recent Developments 2Health News:MGT Capital Investments Reports Third Quarter 2008 Financial Results and Provides Update on Recent Developments 3Health News:TotSpot.com Celebrates Launch With Jenny McCarthy, Joely Fisher, Tori Spelling and Other Celebrity Mommies at The Treehouse Social Club 2Health News:CPhI Conferences to Present Pharma Procurement Leadership Summit on December 10, 2008 in London 2
... ULTRAVIST (iopromide) injection is ... agent for intravascular administration. Introduced in ... after becoming available in Europe, ULTRAVIST ... 75 countries. It has established a ...
The Mitek Restore System, designed in conjunction with Sanford S. Kunkel, M.D., offers instrumentation for all ACL Procedures....
The cordless Simon Dermatome with rechargeable battery is used to harvest split-thickness skin grafts and for debridement....
... quality and innovation has resulted in one ... Model C is an air dermatome especially ... in burn care surgery. The Model C ... same dedication to quality, durability and reliability ...
Medicine Products: